Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JONATHAN C REBOTON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1780603308
CMS profile
983504
Location
LAS VEGAS, NV

General Payments · PY2018

$272.24

  • Reported across 19 records
  • CMS publication 2026-01-23

Latest program year · PY2018

$272.24

19 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2018 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $272.24 19

By paying entity

PY2018 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $272.24 19

Payment records · PY2018 (19)

Sorted by paying entity, then date · as published by CMS

Program year 2018
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Astellas Pharma US Inc $24.65 03/20/2018 Food and Beverage Undisputed 01/23/2026 582479003 CMS
Astellas Pharma US Inc $12.60 12/19/2018 Food and Beverage Undisputed 01/23/2026 582678925 CMS
Astellas Pharma US Inc $16.62 12/20/2018 Food and Beverage Undisputed 01/23/2026 582597293 CMS
AstraZeneca Pharmaceuticals LP $11.31 02/13/2018 Food and Beverage Undisputed 01/23/2026 560215405 CMS
AstraZeneca Pharmaceuticals LP $12.94 06/27/2018 Food and Beverage Undisputed 01/23/2026 560529879 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.63 08/15/2018 Food and Beverage Undisputed 01/23/2026 577803385 CMS
Janssen Pharmaceuticals, Inc $15.09 01/23/2018 Food and Beverage Undisputed 01/23/2026 549437147 CMS
Janssen Pharmaceuticals, Inc $12.47 06/13/2018 Food and Beverage Undisputed 01/23/2026 549437191 CMS
Janssen Pharmaceuticals, Inc $13.89 09/05/2018 Food and Beverage Undisputed 01/23/2026 549812657 CMS
Janssen Pharmaceuticals, Inc $11.79 12/10/2018 Food and Beverage Undisputed 01/23/2026 549812666 CMS
Lilly USA, LLC $14.13 03/22/2018 Food and Beverage Undisputed 01/23/2026 559393349 CMS
Lilly USA, LLC $13.73 04/18/2018 Food and Beverage Undisputed 01/23/2026 559393351 CMS
Merck Sharp & Dohme Corporation $11.71 09/27/2018 Food and Beverage Undisputed 01/23/2026 604630341 CMS
Merck Sharp & Dohme Corporation $11.61 10/25/2018 Food and Beverage Undisputed 01/23/2026 604682143 CMS
Novo Nordisk Inc $13.65 01/16/2018 Food and Beverage Undisputed 01/23/2026 588657773 CMS
Novo Nordisk Inc $11.73 02/14/2018 Food and Beverage Undisputed 01/23/2026 588657775 CMS
Novo Nordisk Inc $14.52 03/14/2018 Food and Beverage Undisputed 01/23/2026 588657771 CMS
Novo Nordisk Inc $14.91 06/14/2018 Food and Beverage Undisputed 01/23/2026 588657769 CMS
Phadia US Inc. $14.26 01/30/2018 Food and Beverage Undisputed 01/23/2026 590556557 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018
Source files
Dataset page · Bulk file · PY2018
Generated from
OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.